Page header image

Aspirin Exacerbated Respiratory Disease (AERD): References

Global Initiative for Asthma (GINA). Global strategy for Asthma Management and Prevention. 2018.

Chang JE, Chin W, Simon R. Aspirin-sensitive asthma and upper airway diseases. Am J Rhinol Allergy. 2012 Jan-Feb; 26(1):27-30.

Chang JE, White A, Simon RA, Stevenson DD. Aspirin-exacerbated respiratory disease: burden of disease. Allergy Asthma Proc. 2012 Mar-Apr;33(2):117-21. doi: 10.2500/aap.2012.33.3541.

Stevens W, Buchheit K, Cahill KN. Aspirin-exacerbated diseases: advances in asthma with nasal polyposis, urticaria, angioedema, and anaphylaxis. Curr Allergy Asthma Rep. 2015 Dec;15(12):69. doi: 10.1007/s11882-015-0569-2. PMID: 26475526.

Pongdee T. Aspirin-exacerbated respiratory disease (AERD). American Academy of allergy Asthma & Immunology. Accessed May 2018.

Bottrell J. Asthma subgroups: aspirin sensitive respiratory disease (AERD). December 13, 2016. Accessed June 2018.

Stevens WW, Peters, AT, Hirsch AG, et al. Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and aspirin-exacerbated respiratory disease (AERD). Journal of Allergy and Clinical Immunology: In Practice, 2017-07-01, Volume 5, Issue 4, Pages 1061-1070.e3.

© 2018 Change Healthcare LLC and/or one of its subsidiaries
Page footer image